NA

Niagen Bioscience Inc

NAGE · Nasdaq

Niagen Bioscience Inc (NAGE) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Niagen Bioscience Inc in 2026. The next earnings report is expected on November 4, 2026.

Earnings calendar

Next earnings date

04 Nov 2026

In 75 days

EPS estimate

0.05

Revenue estimate

36.8M

Past earnings

04 Aug 2026
EPS actual
0.01 (+20.0%)
estimate 0.01
Revenue actual
29.8M (-2.4%)
estimate 30.5M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
06 May 2026
EPS actual
0.07 (+2.9%)
estimate 0.07
Revenue actual
31.5M (+1.4%)
estimate 31.0M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
04 Mar 2026
EPS actual
0.05 (+127.3%)
estimate 0.02
Revenue actual
33.8M (+6.7%)
estimate 31.7M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Beat Miss usd

Latest earnings analysis

Niagen Bioscience Inc beat consensus estimates in its latest earnings report, with EPS of $0.01 versus the $0.0083 consensus and revenue of $29.79 million coming in 2.4% below expectations. In the prior quarter both EPS and revenue were also ahead of expectations.

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

Niagen Bioscience Inc is a bioscience company dedicated to healthy aging. The Company leads research on nicotinamide adenine dinucleotide.

Sector
Healthcare
Industry
Biotechnology
Country
United States
Exchange
Nasdaq
CEO
Robert N. Fried
Employees
104
IPO date
24 Jun 2015
ISIN
US1710774076
Website
niagenbioscience.com

Frequently asked questions

When does Niagen Bioscience Inc (NAGE) next report earnings?

Niagen Bioscience Inc (NAGE) is scheduled to report earnings on November 4, 2026.

What was Niagen Bioscience Inc's most recent earnings date?

Niagen Bioscience Inc (NAGE) last reported earnings on August 4, 2026.

Where is Niagen Bioscience Inc stock listed?

Niagen Bioscience Inc (NAGE) is listed on Nasdaq.